Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05118035
NCT05118035
Completed
Not Applicable

Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality: a Pragmatic Randomized Clinical Trial

National Defense Medical Center, Taiwan1 site in 1 country15,965 target enrollmentDecember 15, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCardiovascular DiseasesIntensity CareMorality

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Diseases
Sponsor
National Defense Medical Center, Taiwan
Enrollment
15965
Locations
1
Primary Endpoint
All cause mortality (death)
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for early detection of clinical deterioration for reducing mortality.

Registry
clinicaltrials.gov
Start Date
December 15, 2021
End Date
December 31, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
National Defense Medical Center, Taiwan
Responsible Party
Principal Investigator
Principal Investigator

Chin Lin

Associate Professor

National Defense Medical Center, Taiwan

Eligibility Criteria

Inclusion Criteria

  • •Patients in emergency department or inpatient department.
  • •Patients recieved at least 1 ECG examination.

Exclusion Criteria

  • •The patients recieved ECG at the period of inactive AI-ECG system.

Outcomes

Primary Outcomes

All cause mortality (death)

Time Frame: Within 90 days

After performing an electrocardiogram, the patient's survival is tracked.

Secondary Outcomes

  • Cardiovascular cause mortality (death)(Within 90 days)
  • Arrhythmia medication(Within 12 hours)
  • Electrolyte examination(Within 3 days)
  • Cadiac examination(Within 3-7 days)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using ElectrocardiogramsLeft Ventricular Systolic Dysfunction (Disorder)
NCT05117970National Defense Medical Center, Taiwan13,631
Completed
Not Applicable
ECG AI-Guided Screening for Low Ejection FractionAsymptomatic Left Ventricular Systolic Dysfunction (Disorder)Heart Failure
NCT04000087Mayo Clinic358
Completed
Not Applicable
Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE)Myocardial Infarction, Acute
NCT05118009National Defense Medical Center, Taiwan43,176
Completed
Not Applicable
Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE)HyperkalemiaHypokalemia
NCT05118022National Defense Medical Center, Taiwan14,989
Completed
Not Applicable
CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation DetectionAtrial Fibrillation New Onset
NCT05127460National Defense Medical Center, Taiwan25,732